Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology - A rebuttal [12] (multiple letters)

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 4, 2005, Pages 816-817

  Vasvari, G ^a   Dyckhoff, G ^a   Herold Mende, C ^a   Kaushal, V ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BENZOIC ACID; CARBOXYMETHYLCELLULOSE; CISPLATIN; CYTOTOXIC AGENT; DIMETHYL SULFOXIDE; DOXORUBICIN; HYDROXYL RADICAL; REACTIVE OXYGEN METABOLITE; SOLVENT; THALIDOMIDE; ANGIOGENESIS INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; HYPERCOAGULABILITY; LETTER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; CELL SIZE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HUMAN; NOTE; PATHOLOGY; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; APOPTOSIS; CARBOXYMETHYLCELLULOSE; CELL LINE, TUMOR; CELL SIZE; CELL SURVIVAL; DIMETHYL SULFOXIDE; DOXORUBICIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; SOLVENTS; THALIDOMIDE;

EID: 23044516676     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01170.x     Document Type: Letter

References (0)